Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Better Buy: Biogen vs. Eli Lilly
10:07am, Tuesday, 29'th Aug 2023
Biogen is adding new products to its lineup to reverse its recent revenue decreases. Eli Lilly has a solid portfolio and strong pipeline, and pays a consistent dividend.
Lilly to Participate in Morgan Stanley 21st Annual Global Healthcare Conference
10:00am, Tuesday, 29'th Aug 2023
INDIANAPOLIS , Aug. 29, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley 21st Annual Global Healthcare Conference, Sept. 11-12, 2023.
Why Wegovy's Sales Potential Could Be Massively Understated
05:47am, Tuesday, 29'th Aug 2023
Wegovy may generate more than $4 billion in revenue this year for Novo Nordisk. A recent study showed the weight-loss drug can also help people bring down their risk of heart attack or stroke.
Eli Lilly's diabetes drug to remain in shortage in EU through September
10:58am, Monday, 28'th Aug 2023
The European Medicines Agency (EMA) said on Monday Eli Lilly & Co's Trulicity, which treats type 2 diabetes in children above 10 years of age, will continue to remain in shortage in Europe through Sep
The 3 Blue-Chip Stocks Every Investor Needs to Own Today
08:10am, Monday, 28'th Aug 2023
Savvy investors understand the beauty of having blue-chip stocks. No wonder financial analysts and market professionals recommend having them in your portfolio.
Want to Get Rich? 3 Game-Changing Growth Stocks to Buy Right Now
05:58am, Monday, 28'th Aug 2023
Growth stocks continue to drive both the stock market and investors' portfolios. Game-changing growth stocks to buy that have multi-year catalysts to drive their earnings and share price steadily high
Is It Too Late to Buy Eli Lilly Stock?
07:20am, Sunday, 27'th Aug 2023
Eli Lilly continued to grow like a weed in the second quarter. The company's dividend payout ratio is somewhat low.
Accused Of Excluding Older Applicants, Eli Lilly Settles Again
06:27am, Sunday, 27'th Aug 2023
Eli Lilly settled another age discrimination lawsuit for an undisclosed amount, just two months after reaching a $2.4 million settlement with the EEOC.
This New Development Is Helping to Send Eli Lilly and Novo Nordisk Stocks Soaring
10:23am, Thursday, 24'th Aug 2023
A new study by Novo Nordisk points to GLP-1 drugs reducing cardiac risks. It's a relevant finding for Eli Lilly, too, which is already moving forward in clinical trials.
Got $5,000? Invest in These 2 Unstoppable Growth Stocks.
09:53am, Wednesday, 23'rd Aug 2023
Eli Lilly could see a couple of key drug approvals from the FDA in the near future. Strong travel demand and an improved platform position Airbnb for continued growth.
Sell Eli Lilly And Buy This Coiled-Spring Dividend Aristocrat Instead
07:00am, Wednesday, 23'rd Aug 2023
The Nasdaq's 15-year period of zero returns highlights the importance of valuation in the long term. Eli Lilly is in an epic bubble, pricing in all growth through 2036 and trading at almost 60X forwar
Could This 1 Problem Put a Dent in Novo Nordisk and Eli Lilly Stock?
10:15am, Tuesday, 22'nd Aug 2023
Novo Nordisk and Eli Lilly want to use their medicines to treat NASH, a liver disease. Their chances of success are more uncertain than shareholders might wish to see.
Eli Lilly reports positive results from study of thyroid cancer treatment
08:32am, Tuesday, 22'nd Aug 2023
Eli Lilly & Co. LLY, +0.66% on Tuesday reported positive results from a study evaluating its targeted therapy Retevmo versus the current standard initial treatments for patients with advanced or metas
These 3 Large-Cap Pharma Stocks Have Been Red-Hot
09:02pm, Monday, 21'st Aug 2023
Large-cap pharmaceuticals have enjoyed buying pressure over the last month, delivering outsized gains to investors. And these three stocks have helped lead the charge.
5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain Pace
11:16am, Monday, 21'st Aug 2023
Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Novartis (NVS) and AstraZeneca (AZN) are wo
